Active Psoriatic Arthritis Market to Exhibit 9.2% CAGR till 2027 | Trend— Growing Prevalence of Psoriasis: Emergen Research
Research Reports
Jan 15, 2021
The global Active Psoriatic Arthritis Market was valued at USD 7.15 billion in 2019 and is expected to reach USD 13.64 billion by 2027, at a CAGR of 9.2%. Significant growth in incidences of active psoriatic arthritis is observed across emerging countries together with increasing elderly population,Market Size – USD 7.15 Billion in 2019, Market Growth – CAGR of 9.2%,
The report on the Global Active Psoriatic Arthritis Market initially offers an in-depth overview of the Active Psoriatic Arthritis Market along with insights into the developments and advancements in the sector. The report offers a comprehensive overview of the regional and competitive landscape and provides a deeper insight into the current market scenario and future growth prospects. The research study also provides a complete analysis of the market drivers, restraints, limitations, threats, risks, and growth opportunities.
Technological progressions in Active Psoriatic Arthritis therapeutics and management, significant prevalence of target disease across the globe, rising awareness towards the availability of biosimilar products for psoriatic arthritis, are among key factors expected to fuel the market growth
Get a sample of the report @ https://www.emergenresearch.com/request-sample-form/72
The report offers a panoramic view of the competitive landscape of the industry and a detailed analysis of the key players of the market based on their revenue, profit margins, financial standing, global market position, R&D activities, and product portfolio. It also covers their strategic endeavors such as mergers and acquisitions, joint ventures, collaborations, partnerships, corporate and government deals, and product launches and brand promotions, among others. The key players profiled in the report are Novartis International AG, Johnson & Johnson Services, AbbVie, AstraZeneca, Amgen, Celgene Corporation, Bristol-Myers Squibb Company, Bausch Health Companies, Eli Lilly and Company and Pfizer among other companies.
Global Active Psoriatic Arthritis Market Segmentation based on Product Types and Application Spectrum:
Product Outlook (Revenue in Million USD; 2017–2027)
- Prescriptions
- OTC
- Other
Drug Class Outlook (Revenue in Million USD; 2017–2027)
- Biologics
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)
- Other
By Route of Administration (Revenue in Million USD; 2017–2027)
- Injectable
- Oral
- Topical
Request a discount on the report @ https://www.emergenresearch.com/request-discount-form/72
Regional Analysis of the Active Psoriatic Arthritis Market Includes:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
The report offers a complete understanding of the Active Psoriatic Arthritis market in key regions with respect to regional production and consumption patterns, import/export, supply and demand dynamics, trends, growth prospects, and the presence of prominent players in each region. Each of the mentioned regions is analyzed based on the comprehensive market data obtained from the major countries of each region to impart a clear understanding of the market.
To know more about the report, visit @ https://www.emergenresearch.com/industry-report/active-psoriatic-arthritis-market
TOC
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Active Psoriatic Arthritis Market Segmentation & Impact Analysis
4.1. Active Psoriatic Arthritis Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Intensifying Prevalence of psoriatic arthritis
4.2.2.2. Emergence of potential medication
4.2.2.3. Healthcare reimbursements scenario
4.2.2.4. Availability of research finds from public and private bodies
4.2.3. Market restraints analysis
4.2.3.1. High cost of treatment
4.2.3.2. Side effects associated with the treatment/surgery
4.3. Technological Insights
4.4. Clinical Pipeline Analysis
4.5. Regulatory Framework
4.6. Porter’s Five Forces Analysis
4.7. Competitive Metric Space Analysis
4.8. Price trend Analysis
4.9. Covid-19 Impact Analysis
Chapter 5. Active Psoriatic Arthritis Market By Product Type Insights & Trends, Revenue (USD Million)
5.1. Product Type Dynamics & Market Share, 2019 & 2027
5.1.1. Prescriptions Products
5.1.2. Over-the-Counter (OTC)
5.1.3. Other
To Be Continued…!
Request customization of the report @ https://www.emergenresearch.com/request-for-customization-form/72
Thank you for reading our report. To request a customization or for further inquiries, kindly get in touch with us. Our team will ensure the report is tailored meet to your needs.
Take a Look at our Related Reports:
Automotive MEMS Sensor Market Size To Be Worth USD 4.84 Billion by 2027 | Emergen Research
Mobile C-Arms Market To Be Worth USD 1.61 Billion By 2027 Growing at a CAGR of 5.2% | Emergen Research
Mobility as a Service Market Size Worth USD 523.61 Billion by 2027 | Emergen Research
Counter UAS Market To Reach USD 4.70 Billion By 2027 Growing at a CAGR of 26.8% | Emergen Research
Gallium Nitride Market Size To Be Worth USD 320.4 Million by 2027 Growing at a CAGR of 20.8%| Emergen Research
Thermoelectric Materials Market Size Worth USD 96.2 Million by 2027 | Emergen Research
Tags:
, Reportedtimes, Research Newswire, English